Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro
- 1 February 1985
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 37 (4) , 493-502
- https://doi.org/10.1016/0049-3848(85)90095-7
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980
- A randomized, controlled trial of aspirin in persons recovered from myocardial infarctionPublished by American Medical Association (AMA) ,1980
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTIONThe Lancet, 1979
- A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened StrokeNew England Journal of Medicine, 1978
- Sulfinpyrazone in the Prevention of Cardiac Death after Myocardial InfarctionNew England Journal of Medicine, 1978
- Controlled trial of aspirin in cerebral ischemia.Stroke, 1977
- Aspirin in coronary heart diseaseJournal of Chronic Diseases, 1976
- A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial InfarctionBMJ, 1974
- Arteriovenous-Shunt ThrombosisNew England Journal of Medicine, 1974